Cara Therapeutics, Inc. (CARA)

NASDAQ: CARA · IEX Real-Time Price · USD

0.684

-0.016 (-2.24%)

At close: Apr 26, 2024, 4:00 PM

0.695

+0.011 (1.55%)

After-hours: Apr 26, 2024, 4:13 PM EDT

Cara Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Net Income	-118.51	-85.47	-88.44	8.41	-106.37	-74.01	-58.13	-57.28	-24.69	-17.75	Upgrade
Depreciation & Amortization	2.33	1.67	1.55	1.02	0.8	0.37	0.5	1.47	0.84	0.78	Upgrade
Share-Based Compensation	13.73	17.73	20.79	14.84	12.57	10.09	6.33	2.8	2.51	1.37	Upgrade
Other Operating Activities	10.37	-12.66	6.02	-29.75	-16.22	41.25	-3.53	5.63	-0.14	-2.05	Upgrade
Operating Cash Flow	-92.08	-78.73	-60.09	-5.49	-109.23	-22.3	-54.83	-47.38	-21.48	-17.64	Upgrade
Capital Expenditures	-2.38	-0.04	0.03	-0.35	-0.02	-0.07	-0.02	-0.72	-0.02	-0.04	Upgrade
Change in Investments	45.84	128.75	-4.78	-19.93	-30.5	-82.75	-36.48	45.74	-91.66	0	Upgrade
Investing Cash Flow	43.46	128.71	-4.75	-20.28	-30.52	-82.82	-36.5	45.02	-91.68	-0.04	Upgrade
Share Issuance / Repurchase	1.68	0.31	46.61	39.14	142.6	110.81	87.92	0.12	75.59	57.99	Upgrade
Debt Issued / Paid	36.47	0	0	0	0	0	0	0	0	0	Upgrade
Financing Cash Flow	38.15	0.31	46.61	39.14	142.6	110.81	87.92	0.12	75.59	57.99	Upgrade
Net Cash Flow	-10.47	50.29	-18.23	13.38	2.86	5.69	-3.4	-2.24	-37.56	40.31	Upgrade
Free Cash Flow	-94.45	-78.77	-60.06	-5.84	-109.24	-22.37	-54.84	-48.1	-21.5	-17.68	Upgrade
Free Cash Flow Margin	-450.46%	-188.15%	-260.80%	-4.32%	-549.35%	-166.11%	-6020.20%	-55927.91%	-565.29%	-556.63%	Upgrade
Free Cash Flow Per Share	-1.74	-1.47	-1.18	-0.12	-2.56	-0.62	-1.76	-1.76	-0.87	-0.84	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).